LAMCX
Price
$24.10
Change
-$0.03 (-0.12%)
Updated
Nov 13 closing price
VTSAX
Price
$144.14
Change
-$0.09 (-0.06%)
Updated
Nov 13 closing price
Ad is loading...

LAMCX vs VTSAX

Header iconLAMCX vs VTSAX Comparison
Open Charts LAMCX vs VTSAXBanner chart's image
Lord Abbett Dividend Growth C
Price$24.10
Change-$0.03 (-0.12%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.14
Change-$0.09 (-0.06%)
VolumeN/A
CapitalizationN/A
LAMCX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LAMCX vs. VTSAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAMCX is a Buy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. LAMCX (4.39B). VTSAX pays higher dividends than LAMCX: VTSAX (1.35) vs LAMCX (0.08). LAMCX was incepted earlier than VTSAX: LAMCX (23 years) vs VTSAX (24 years). LAMCX is a more actively managed with annual turnover of: 35.00 vs. VTSAX (2.00). LAMCX has a lower initial minimum investment than VTSAX: LAMCX (1000) vs VTSAX (3000). LAMCX (34.22) and VTSAX (33.39) have marching annual gain over last year. VTSAX return over 5 years is better than : 87.46 vs. LAMCX (51.30).
LAMCXVTSAXLAMCX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years24 years-
Gain YTD26.40124.891106%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets4.39B1.73T0%
Annual Yield % from dividends0.081.356%
Returns for 1 year34.2233.39102%
Returns for 3 years12.3422.8254%
Returns for 5 years51.3087.4659%
Returns for 10 years51.39194.0726%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals